| Untreated (n = 19) | Treated (n = 25) | ||||
---|---|---|---|---|---|---|
Hypertrophy | Vascularity | Echogenicity | Hypertrophy | Vascularity | Echogenicity | |
IL-6 | 0.75* | 0.80* | 0.01 | 0.38 | 0.65* | −0.46* |
VEGF | 0.21 | 0.68* | 0.15 | 0.28 | 0.43* | −0.55* |
IL-8 | 0.30 | 0.41 | − 0.15 | 0.13 | 0.33 | −0.17 |
TNF-α | 0.29 | 0.37 | 0.01 | 0.09 | 0.11 | 0.08 |
IL-1β | 0.49* | 0.65* | 0.05 | 0.27 | 0.27 | −0.03 |
IL-10 | 0.68* | 0.68* | 0.16 | 0.32 | 0.39 | −0.35 |
IL-17A | 0.63* | 0.47* | 0.20 | 0.14 | 0.31 | −0.17 |
Fractalkine | 0.36 | 0.46* | 0.02 | 0.24 | 0.21 | −0.12 |
Granzyme B | 0.60* | 0.63* | −0.02 | 0.15 | 0.17 | 0.27 |